Last reviewed · How we verify
Nirapaib
At a glance
| Generic name | Nirapaib |
|---|---|
| Also known as | Zejula |
| Sponsor | Michelle S Ludwig |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | discontinued |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |